Back to Search
Start Over
Medical cannabis and its effect on oncological outcomes in patients with ovarian cancer treated with PARP inhibitors
- Source :
- International Journal of Gynecological Cancer; April 2024, Vol. 34 Issue: 4 p559-565, 7p
- Publication Year :
- 2024
-
Abstract
- Poly (ADP-ribose) polymerase inhibitors (PARPi) play a pivotal role in ovarian cancer management. With medical cannabis emerging as a novel component of supportive care, this study investigated the impact of medical cannabis use on oncological outcomes in patients with ovarian cancer undergoing PARPi therapy.
Details
- Language :
- English
- ISSN :
- 1048891X and 15251438
- Volume :
- 34
- Issue :
- 4
- Database :
- Supplemental Index
- Journal :
- International Journal of Gynecological Cancer
- Publication Type :
- Periodical
- Accession number :
- ejs68486858
- Full Text :
- https://doi.org/10.1136/ijgc-2023-004953